| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-09 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-08 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-07 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |